| Type |
Form D Funds |
Date |
Sold |
AUM |
| PE |
EMR Capital Co-Investment IX LP |
[2022-03-31]
|
|
24.3 M |
|
Filed 2020-03-06 (D) · Exemption 506(b), 3(c), 3(c)(7) · Remaining Indefinite · Duration One year or less · Revenue Decline to Disclose
|
| PE |
EMR Capital Co-Investment VIII LP |
[2021-03-31]
|
|
70.4 M |
|
Filed 2020-03-06 (D) · Exemption 506(b), 3(c), 3(c)(7) · Remaining Indefinite · Duration One year or less · Revenue Decline to Disclose
|
| PE |
EMR Capital Co-Investment VII LP |
[2021-03-31]
|
|
14.2 M |
|
Filed 2020-03-06 (D) · Exemption 506(b), 3(c), 3(c)(7) · Remaining Indefinite · Duration One year or less · Revenue Decline to Disclose
|
| PE |
EMR Capital Co-Investment VI LP |
[2020-03-30]
|
|
76.7 M |
|
Filed 2019-05-24 (D) · Exemption 506(b), 3(c), 3(c)(7) · Remaining Indefinite · Duration One year or less · Revenue Decline to Disclose
|
| PE |
EMR Capital Co-Investment V LP |
[2020-03-30]
|
|
37.6 M |
|
Filed 2019-05-08 (D) · Exemption 506(b), 3(c), 3(c)(7) · Remaining Indefinite · Duration One year or less · Revenue Decline to Disclose
|
| PE |
EMR Capital Resources Fund III LP |
[2020-03-30]
|
|
225.9 M |
|
Offered $1,300,000,000 · Filed 2019-05-16 (D) · Exemption 506(b), 3(c), 3(c)(7) · Remaining $1,300,000,000 · Duration One year or less · Commission $12,000,000 · Revenue Decline to Disclose
|
| PE |
EMR Capital Co-Investment III LP |
[2019-03-31]
|
54.5 M |
89.2 M |
|
Filed 2019-06-27 (D/A) · Exemption 506(b), 3(c), 3(c)(7) · Remaining Indefinite · Duration One year or less · Revenue Decline to Disclose
|
| PE |
EMR Capital Resources Fund II LP |
[2016-09-28]
|
837.2 M |
83.9 M |
|
Offered $875,000,000 · Filed 2016-10-13 (D/A) · Exemption 506(b), 3(c), 3(c)(7) · Remaining $37,795,000 · Duration More than one year · Commission $7,550,000 · Revenue Decline to Disclose
|